Evidence map›Paper›PMID 39525972›Full record

ArticleBio-protocol2024

PEPITA: Parallelized High-Throughput Quantification of Ototoxicity and Otoprotection in Zebrafish Larvae.

Elizabeth M Nilles, Ethan Bustad, Meng Qin, Emma Mudrock, Alden Gu, Louie Galitan, Henry C Ou, Rafael E Hernandez, Shuyi Ma

Abstract read
In one paragraph

Article in Bio-protocol, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Elizabeth M NillesCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA.
Ethan BustadCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA.
Meng QinCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA.
Emma MudrockCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA.
Alden GuCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA.
Louie GalitanCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA.
Henry C OuDepartment of Pediatrics, University of Washington, Seattle, WA, USA.
Rafael E HernandezCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA.
Shuyi MaCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, USA.

Funding

Seattle Tuberculosis Research Advancement CenterP30AI168034 · NIAID · UNIVERSITY OF WASHINGTON · PI Rhea N Coler, CHETAN SESHADRI · 2022 to 2026
$6.3M
Transcriptome-driven inference of adverse drug interactionsR21DC018341 · NIDCD · SEATTLE CHILDREN'S HOSPITAL · PI MA, SHUYI · 2021 to 2023
$558k
NIAID NIH HHS P30 AI168034NIDCD NIH HHS R21 DC018341
6 · The paper itself

Abstract

Drug-induced hearing injury (ototoxicity) is a common, debilitating side effect of many antibiotic regimens that can be worsened by adverse drug interactions. Such adverse drug interactions are often not detected until after drugs are already on the market because of the difficulty of measuring all possible drug combinations. While in vivo mammalian assays to screen for ototoxic damage exist, they are currently time-consuming, costly, and limited in throughput, which limits their utility in assessing drug interaction outcomes. To facilitate more rapid quantification of ototoxicity and assessment of adverse drug interactions that impact ototoxicity, we have developed a high-throughput workflow we call parallelized evaluation of protection and injury for toxicity assessment (PEPITA). PEPITA uses zebrafish larvae to quantify ototoxic damage and protection. Previous work has shown that hair cells (HCs) in the zebrafish lateral line are very similar to human inner ear HCs, meaning zebrafish are a viable model to test drug-induced ototoxicity. In PEPITA, we expose zebrafish larvae to different combinations of drugs, fluorescently label the HCs, and subsequently use microscopy to quantify the brightness of the fluorescently labeled HCs as an assay for ototoxic damage and hair-cell viability. PEPITA is a reproducible, low-cost, technically accessible, and high-throughput assay. These advantages allow many experiments to be conducted in parallel, paving the way for systematic evaluation of drug-induced hearing injury and other multidrug interactions. Key features • Analysis of drug-induced hair cell damage associated with ototoxicity using

Indexed as

Automated image analysisDrug–drug interactionMicroscopyOtoprotectionOtotoxicityZebrafish

Identifiers

PMID39525972
PMCPMC11543779

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.